SUBSCRIBE
SUBSCRIBE
News   Business

Valeant Pharmaceuticals International Mourns Death Of Chairman Robert W. O’Leary; Board Of Directors Elects Robert A. Ingram As Chairman Of The Board

August 15, 2006 | 
1 min read
Valeant Pharmaceuticals International (NYSE:VRX) announced with great sadness today that Robert W. O'Leary, who served as its chairman of the board over the past four years, died this morning at the age of 62, following a long battle with cancer.
People
Valeant Pharmaceuticals International
MORE ON THIS TOPIC
Auxilium Pharmaceuticals Drug Found Effective Against Cellulite In Phase 2 Study
IN PARTNERSHIP WITH EVOTEC
Strategic Drug Development in a Funding Crisis: Expert Insights on Risk Profiling, Efficiency, and Innovation
October 13, 2025
 · 
8 min read
 · 
BioSpace Insights
Facade of AstraZeneca's office in Shanghai, China
Drug pricing
AstraZeneca Becomes Second Pharma to Strike DTC Deal With Trump Administration
October 10, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Ferring To Cut 500 Employees as Part of Business Model Shift
October 10, 2025
 · 
70 min read
 · 
BioSpace Editorial Staff
External view of Bristol Myers Squibb's office California
Mergers & acquisitions
BMS Makes $1.5B Cell Therapy Play With Orbital Takeover
October 10, 2025
 · 
2 min read
 · 
Tristan Manalac